Innate Pharma S.A. operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Innate Pharma S.A. with three other
companies in this sector in France:
sales of 51.01 million Euro [US$60.29 million]
of which 105%
(23.44 million Euro [US$27.70 million]
(22.49 million Euro [US$26.58 million]
of which 100%
was Regenerative Medicine).
Sales increased substantially in 2016:
Innate Pharma S.A. reported sales of 56.16 million Euro (US$66.38 million)
December of 2016.
increase of 213.6%
versus 2015, when the company's sales were 17.91 million Euro.